FirstWord Pharma - referenced from The Irish Times Please link to the article below which was posted in Sept 2014 by firstwordpharma.com website. The post refers to an Irish Times article reporting that Sigmoid Pharma entered into an exclusive licence agreement with Pendopharm to commercialise its product to treat ulcerative colitis. The agreement amounts to a €5m investment. You can read the full article by clicking on the button below. FirstWord Pharma Article - "Sigmoid Pharma raises €5m investment from Pendopharm"
Irish Independent - Business Article by Roisin Burke Please link to the article below which was posted in Apr 2014 by independent.ie website. It reports how Sigmoid Pharma is considering a €30m Nasdaq float over the next 12 months. Sigmoid Pharma develop potentially ground-breaking biotech products and is backed by Irrus Investments and Glen Dimplex founder Martin Naughton among others. You can read the full article by clicking on the button below. Irish Independent Business Article - "Sigmoid planning $30m Nasdaq float"